AFP and neoplasm: On day 21 after tumor implantation, the AFP concentration in the vehicle group was 1,752,948 ± 1,338,693 ng/mL and that in the CBT-143-S-F6F7-treated group was 1,312,510 ± 944,306 ng/mL (P = 0.24, Fig. 4b).